GENEWIZ from Azenta Life Sciences, announced the launch of Gene Synthesis 2.0. This updated service platform simplifies how researchers design and order genes, reducing complexity while accelerating ...
Scientists at the University of Rochester pulled off a remarkable experiment: they transferred a longevity-related gene from the famously long-lived naked mole rat into mice, and the mice ended up ...
Genewiz, Azenta Life Sciences’ genomics services provider, launched Gene Synthesis 2.0, an updated platform designed to simplify how researchers design and order genes. Built around three packages, ...
Two studies led by the Chahrour Lab at UT Southwestern Medical Center shed new light on genes associated with autism spectrum disorder (ASD), the neurodevelopmental disease characterized by impaired ...
Physician and molecular biologist Katherine High remembers sitting at a staff meeting of the gene therapy company Spark Therapeutics on November 15, 2018, waiting to hear from a guest speaker, when ...
Travis Smith was a very serious baby. Born completely unable to hear, his mother, Sierra, struggled to see his personality shine through his mute world. “My son was 100% deaf,” Smith told Fierce ...
The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time treatment that proved to be life-changing for a small number of children in a ...
An experimental gene therapy appears safe and highly effective for restoring hearing to people born with a rare form of deafness, researchers reported Wednesday. The study, the largest and longest to ...
BEIJING, April 15, 2026 /PRNewswire/ -- As the pace of biotechnology research accelerates, companies are increasingly challenged to balance rapid innovation with the protection of sensitive genetic ...
A new paper in Molecular Biology and Evolution, finds that changes in animal development induced by climate shock persist generations after the initial event. The escalating effects of climate change ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results